Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Pozycja w akcjach #2089
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Cena akcji
$142.76
Kapitalizacja rynkowa
$9.90B
Zmiana (1 dzień)
0.08%
Zmiana (1 rok)
-56.60%
Kraj
US
Handel Insulet Corp. (PODD)

Kategoria

Healthcare
Historia ceny akcji dla Insulet Corp. (PODD)
Najwyższa cena zamknięcia: $137.07 dnia 2026-10-01

Najniższa cena zamknięcia: $15.32 dnia 2007-05-01
Historia cen akcji firmy Insulet Corp. od 2007 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -28.61%
2025 10.94%
2024 29.28%
2023 -31.55%
2022 12.13%
2021 7.15%
2020 41.98%
2019 122.73%
2018 14.06%
2017 87.47%
2016 -0.45%
2015 -18.45%
2014 23.64%
2013 70.93%
2012 17.30%
2011 23.42%
2010 14.55%
2009 83.92%
2008 -70.52%
2007 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$99.01 -22.37%
US
$93.47 -2.46%
IE
$297.49 -21.66%
US
$44.50 -55.46%
US
$46.69 -17.17%
DE